NVCR
NovoCure LimitedWhen NVCR passed all Ten ChecksNovoCure Limited
history · not a forecastOver the past 10 years, NVCR has passed all Ten Checks on 7 separate days. Here is how it moved over the 20 trading sessions that followed — how far it rose, and how far it fell.
The strongest of them rose +11.3% in Feb 2020, peaked day 10.
- Jul 2025+3.2% -38.6%
- Mar 2024+5.2% -20.5%
- Feb 2020+11.3% -19.4%
Peak and dip mark the highest and lowest closing prices over those 20 sessions; the intraday swings ran wider still, and neither figure is a return you could have captured by buying and selling at the perfect moment. These are historical readings from the past 10 years, drawn only from the US-listed stocks the site covers today — a record of what happened, not a prediction of what will, and not investment advice.
6-month history — checks vs. price
Price on the left axis; checks passing (0–10) on the right.
Common questions about NVCR’s checks
How many technical checks does NVCR pass right now?
As of the Aug 27, 2026 close, NVCR passes 8 of 10 fixed technical checks — the checks not passing: not overextended, stop distance within range.
Why does NVCR fail the "stop distance within range" check?
A stop at $16.32 is 9.3% below NVCR's price — wider than the 8% ceiling, so the risk check fails (too much risk per share). It passes once that distance is back inside 2–8%.
What price would change NVCR's check count?
The nearest flip level is "holding above short-term average" fails on a close below $17.42. Each price-anchored check has an exact next-close level, shown in the Flip levels panel above.
Factual measurements from the latest scan — not investment advice.